249 related articles for article (PubMed ID: 6504667)
1. [Value of prostaglandin E1 in cardiac malformations in the newborn infant].
Sassolas F; Bozio A; Andre M; Jocteur-Monrozier D; Champsaur G; Normand J
Pediatrie; 1984 Jun; 39(4):245-52. PubMed ID: 6504667
[TBL] [Abstract][Full Text] [Related]
2. Use of prostaglandin E1 for maintaining the patency of the ductus arteriosus.
Noah ML
Adv Prostaglandin Thromboxane Res; 1978; 4():355-62. PubMed ID: 347914
[TBL] [Abstract][Full Text] [Related]
3. Nursing care of the neonate receiving prostaglandin E1 therapy.
Rikard DH
Neonatal Netw; 1993 Jun; 12(4):17-22. PubMed ID: 8510622
[TBL] [Abstract][Full Text] [Related]
4. [Effects of prostaglandin in heart abnormalities with needed patency of the arterial canal (clinical and histological study)].
Moulaert A; Gittenberger-De Groot A; Harinck E
Arch Fr Pediatr; 1978; 35(7):717-25. PubMed ID: 736728
[TBL] [Abstract][Full Text] [Related]
5. Modified Blalock-Taussig shunt following long-term administration of prostaglandin E1 for ductus-dependent neonates with cyanotic congenital heart disease.
Yokota M; Muraoka R; Aoshima M; Nomoto S; Shiraishi Y; Kyoku I; Kitano M; Shimada I; Nakano H; Ueda K
J Thorac Cardiovasc Surg; 1985 Sep; 90(3):399-403. PubMed ID: 4033176
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandins and the management of congenital heart disease.
Taylor WJ; Alpert BS
Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E1 in infants with congenital heart disease: Indian experience.
Saxena A; Sharma M; Kothari SS; Juneja R; Reddy SC; Sharma R; Bhan A; Venugopal P
Indian Pediatr; 1998 Nov; 35(11):1063-9. PubMed ID: 10216540
[TBL] [Abstract][Full Text] [Related]
8. [Effect of prostaglandin E1 on the hemodynamics in newborn infants with pulmonary atresia (author's transl)].
Mocellin R; Sauer U; Schumacher G; Kellner M; Schöber JG
Z Kardiol; 1978 Aug; 67(8):572-7. PubMed ID: 695809
[TBL] [Abstract][Full Text] [Related]
9. [Prostaglandin E1 therapy in infants with cyanotic congenital heart malformations: hemodynamic and angiographic findings (author's transl)].
Schumacher G; Mocellin R; Schöber JG; Kellner M; Bühlmeyer K
Klin Padiatr; 1978 Sep; 190(5):465-73. PubMed ID: 568198
[TBL] [Abstract][Full Text] [Related]
10. [Prostaglandins E1 in the treatment of neonatal cardiopathies related to ductus arteriosus. 19 cases].
Maesen Y; Bosi G; Stijns M; Vliers A
Arch Mal Coeur Vaiss; 1981 May; 74(5):579-85. PubMed ID: 6794479
[TBL] [Abstract][Full Text] [Related]
11. Administration of prostaglandin E1 in neonates with critical congenital cardiac defects.
Lewis AB; Takahashi M; Lurie PR
J Pediatr; 1978 Sep; 93(3):481-5. PubMed ID: 690772
[TBL] [Abstract][Full Text] [Related]
12. [Anesthesia for neonates and young infants with ductus dependent cardiac malformations treated with prostaglandin E1].
Fujii S; Nagai I; Yonei A; Sari A; Baba K
Masui; 1984 May; 33(5):545-9. PubMed ID: 6540818
[No Abstract] [Full Text] [Related]
13. Role of prostaglandin E1 and E2 in the management of neonatal heart disease.
Olley PM; Coceani F; Rowe RD
Adv Prostaglandin Thromboxane Res; 1978; 4():345-53. PubMed ID: 645511
[No Abstract] [Full Text] [Related]
14. E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.
Olley PM; Coceani F; Bodach E
Circulation; 1976 Apr; 53(4):728-31. PubMed ID: 56243
[TBL] [Abstract][Full Text] [Related]
15. Ductus arteriosus dilatation by prostaglandin E1 in infants with pulmonary atresia.
Heymann MA; Rudolph AM
Pediatrics; 1977 Mar; 59(3):325-9. PubMed ID: 840551
[TBL] [Abstract][Full Text] [Related]
16. Proceedings: Emergency treatment of certain cyanotic heart defects with prostaglandin E2.
Olley PM; Coceani F
Br Heart J; 1976 Aug; 38(8):877. PubMed ID: 973917
[No Abstract] [Full Text] [Related]
17. Effects of prostaglandin E1 infusion in the pre-operative management of critical congenital heart disease.
Ohara T; Ogata H; Fujiyama J; Murata Y; Abe J; Kakuta K; Hayamizu S; Kameyama S; Yoshida Y
Tohoku J Exp Med; 1985 Jun; 146(2):237-49. PubMed ID: 4040664
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E1 in neonates with critical congenital heart disease.
Dungan WT; Norton JB; Readinger RI; Sotomora RF
J Ark Med Soc; 1982 Oct; 79(5):167-70. PubMed ID: 6183249
[No Abstract] [Full Text] [Related]
19. Effects of prostaglandins and blockers of prostaglandin synthesis on the ductus arteriosus: animal and human studies.
Heymann MA; Rudolph AM
Adv Prostaglandin Thromboxane Res; 1978; 4():363-72. PubMed ID: 645512
[No Abstract] [Full Text] [Related]
20. Pharmacologic dilatation of the ductus arteriosus with prostaglandin E1 in infants with congenital heart disease.
Graham TP; Atwood GF; Boucek RJ
South Med J; 1978 Oct; 71(10):1238-41, 1246. PubMed ID: 81528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
